142: CONVERT – An international randomised trial of concurrent chemo-radiotherapy (cCTRT) comparing twice-daily (BD) and once-daily (OD) radiotherapy schedules in patients with limited stage small cell lung cancer (LS-SCLC) and good performance status (PS)

enthalten in: Lung cancer | 2017

von Faivre-Finn, C. | Snee, M. | Ashcroft, L. | +17

PD-079 Should chemotherapy combinations for advanced non-small cell lung cancer (NSCLC) be platinum-based? A literature-based meta-analysis of phase III randomised trials

enthalten in: Lung cancer | 2005

von Pujol, J. | Barlesi, F. | Daures, J.